This report analyzes the worldwide markets for Chronic Obstructive Pulmonary Disease in US$ Million. The report provides separate comprehensive analytics for US and Rest of World. Annual forecasts are provided for each region for the period 2006 through 2015. Continue Reading

Pharmaceutical companies could substantially reduce the expense of costly treatments for cancer and other diseases produced from mammalian or bacterial cells by growing these human therapeutic proteins in algae-rapidly growing aquatic plant cells that have recently gained attention for their ability to produce biofuels. Continue Reading

Data from two Phase III studies of Merck’s investigational fixed-dose combinations of mometasone furoate and formoterol fumarate (MF/F) were presented by researchers today in two poster presentations at the American Academy of Allergy, Asthma Immunology (AAAAI) annual meeting. Continue Reading